159 related articles for article (PubMed ID: 32561098)
1. Better survival after surgery of the primary tumor in stage IV inflammatory breast cancer.
van Uden DJP; van Maaren MC; Strobbe LJA; Bult P; Stam MR; van der Hoeven JJ; Siesling S; de Wilt JHW; Blanken-Peeters CFJM
Surg Oncol; 2020 Jun; 33():43-50. PubMed ID: 32561098
[TBL] [Abstract][Full Text] [Related]
2. Metastatic behavior and overall survival according to breast cancer subtypes in stage IV inflammatory breast cancer.
van Uden DJP; van Maaren MC; Strobbe LJA; Bult P; van der Hoeven JJ; Siesling S; de Wilt JHW; Blanken-Peeters CFJM
Breast Cancer Res; 2019 Oct; 21(1):113. PubMed ID: 31623649
[TBL] [Abstract][Full Text] [Related]
3. The Impact of Residual Disease After Preoperative Systemic Therapy on Clinical Outcomes in Patients with Inflammatory Breast Cancer.
Nakhlis F; Regan MM; Warren LE; Bellon JR; Hirshfield-Bartek J; Duggan MM; Dominici LS; Golshan M; Jacene HA; Yeh ED; Mullaney EE; Overmoyer B
Ann Surg Oncol; 2017 Sep; 24(9):2563-2569. PubMed ID: 28560598
[TBL] [Abstract][Full Text] [Related]
4. Development of CNS metastases and survival in patients with inflammatory breast cancer.
Uemura MI; French JT; Hess KR; Liu D; Raghav K; Hortobagyi GN; Arun BK; Valero V; Ueno NT; Alvarez RH; Woodward WA; Debeb BG; Moulder SL; Lim B; Tripathy D; Ibrahim NK
Cancer; 2018 Jun; 124(11):2299-2305. PubMed ID: 29579338
[TBL] [Abstract][Full Text] [Related]
5. Can locoregional treatment of the primary tumor improve outcomes for women with stage IV breast cancer at diagnosis?
Nguyen DH; Truong PT; Alexander C; Walter CV; Hayashi E; Christie J; Lesperance M
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):39-45. PubMed ID: 22330986
[TBL] [Abstract][Full Text] [Related]
6. Radiotherapy and Male Breast Cancer: A Population-based Registry Analysis.
Madden NA; Macdonald OK; Call JA; Schomas DA; Lee CM; Patel S
Am J Clin Oncol; 2016 Oct; 39(5):458-62. PubMed ID: 24781343
[TBL] [Abstract][Full Text] [Related]
7. Identifying factors that impact survival among women with inflammatory breast cancer.
Dawood S; Ueno NT; Valero V; Woodward WA; Buchholz TA; Hortobagyi GN; Gonzalez-Angulo AM; Cristofanilli M
Ann Oncol; 2012 Apr; 23(4):870-5. PubMed ID: 21765048
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcome in women with HER2-positive de novo or recurring stage IV breast cancer receiving trastuzumab-based therapy.
Rossi V; Nolè F; Redana S; Adamoli L; Martinello R; Aurilio G; Verri E; Sapino A; Viale G; Aglietta M; Montemurro F
Breast; 2014 Feb; 23(1):44-9. PubMed ID: 24210572
[TBL] [Abstract][Full Text] [Related]
9. 10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study.
van Maaren MC; de Munck L; de Bock GH; Jobsen JJ; van Dalen T; Linn SC; Poortmans P; Strobbe LJA; Siesling S
Lancet Oncol; 2016 Aug; 17(8):1158-1170. PubMed ID: 27344114
[TBL] [Abstract][Full Text] [Related]
10. Comparison of survival in non-metastatic inflammatory and other T4 breast cancers: a SEER population-based analysis.
Jiao D; Zhang J; Zhu J; Guo X; Yang Y; Xiao H; Liu Z
BMC Cancer; 2021 Feb; 21(1):138. PubMed ID: 33549037
[TBL] [Abstract][Full Text] [Related]
11. Impact of time to surgery after neoadjuvant chemotherapy in operable breast cancer patients.
Omarini C; Guaitoli G; Noventa S; Andreotti A; Gambini A; Palma E; Papi S; Tazzioli G; Balduzzi S; Dominici M; Cascinu S; Piacentini F
Eur J Surg Oncol; 2017 Apr; 43(4):613-618. PubMed ID: 27793416
[TBL] [Abstract][Full Text] [Related]
12. Primary tumor extirpation in breast cancer patients who present with stage IV disease is associated with improved survival.
Lang JE; Tereffe W; Mitchell MP; Rao R; Feng L; Meric-Bernstam F; Bedrosian I; Kuerer HM; Hunt KK; Hortobagyi GN; Babiera GV
Ann Surg Oncol; 2013 Jun; 20(6):1893-9. PubMed ID: 23306905
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with improved outcomes for metastatic inflammatory breast cancer patients.
Weiss A; Menen RS; Lin HY; Shen Y; Rosso KJ; Shaitelman S; Woodward W; Valero V; Ueno NT; Bedrosian I; Babiera G
Breast Cancer Res Treat; 2018 Jun; 169(3):615-623. PubMed ID: 29460033
[TBL] [Abstract][Full Text] [Related]
14. Breast conserving surgery (BCS) with adjuvant radiation therapy showed improved prognosis compared with mastectomy for early staged triple negative breast cancer patients Running title: BCS had better prognosis than mastectomy for early TNBC patients.
Wang SE; Sun YD; Zhao SJ; Wei F; Yang G
Math Biosci Eng; 2019 Sep; 17(1):92-104. PubMed ID: 31731341
[No Abstract] [Full Text] [Related]
15. Comparison of Treatment Outcomes With Breast-conserving Surgery Plus Radiotherapy Versus Mastectomy for Patients With Stage I Breast Cancer: A Propensity Score-matched Analysis.
Wang J; Wang S; Tang Y; Jing H; Sun G; Jin J; Liu Y; Song Y; Wang W; Fang H; Ren H; Yu Z; Li Y
Clin Breast Cancer; 2018 Oct; 18(5):e975-e984. PubMed ID: 30054238
[TBL] [Abstract][Full Text] [Related]
16. Overall survival differences between patients with inflammatory and noninflammatory breast cancer presenting with distant metastasis at diagnosis.
Fouad TM; Kogawa T; Liu DD; Shen Y; Masuda H; El-Zein R; Woodward WA; Chavez-MacGregor M; Alvarez RH; Arun B; Lucci A; Krishnamurthy S; Babiera G; Buchholz TA; Valero V; Ueno NT
Breast Cancer Res Treat; 2015 Jul; 152(2):407-16. PubMed ID: 26017070
[TBL] [Abstract][Full Text] [Related]
17. Should breast surgery be considered for patients with de novo metastatic inflammatory breast cancer?
Drapalik LM; Shenk R; Rock L; Simpson A; Amin AL; Miller ME
Am J Surg; 2024 Jul; 233():52-60. PubMed ID: 38458830
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Survival Rates After a Combination of Local Treatment and Systemic Therapy vs Systemic Therapy Alone for Treatment of Stage IV Non-Small Cell Lung Cancer.
Uhlig J; Case MD; Blasberg JD; Boffa DJ; Chiang A; Gettinger SN; Kim HS
JAMA Netw Open; 2019 Aug; 2(8):e199702. PubMed ID: 31433481
[TBL] [Abstract][Full Text] [Related]
19. Surgery Versus Chemotherapy and Radiotherapy For Early and Locally Advanced Small Cell Lung Cancer: A Propensity-Matched Analysis of Survival.
Wakeam E; Acuna SA; Leighl NB; Giuliani ME; Finlayson SRG; Varghese TK; Darling GE
Lung Cancer; 2017 Jul; 109():78-88. PubMed ID: 28577955
[TBL] [Abstract][Full Text] [Related]
20. Primary tumor resection as a component of multimodality treatment may improve local control and survival in patients with stage IV inflammatory breast cancer.
Akay CL; Ueno NT; Chisholm GB; Hortobagyi GN; Woodward WA; Alvarez RH; Bedrosian I; Kuerer HM; Hunt KK; Huo L; Babiera GV
Cancer; 2014 May; 120(9):1319-28. PubMed ID: 24510381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]